DUBLIN, October 11, 2017 /PRNewswire/ --
The "Inhaled Drug Delivery" conference has been added to Research and Markets' offering.
Industry case studies, regulatory updates, latest therapies and technology innovations
This annual conference includes presentations on each of the four principal technologies of inhaled drug delivery - dry powder inhalers, metered dose inhalers, nebulizers and liquid inhalers. It will also cover the future European and UK regulatory processes following Brexit, which will be critical when developing product approval strategies in the future.
There are a number of key areas that are currently evolving and the latest thinking and progress on these will also be presented, including Human factor design and sensing/connecting technologies. These key evolving areas are subject to much debate and require careful consideration whilst developing an inhaled drug product.
Programme to include:
- Future needs for inhaled drug delivery
- Innovation in nebulized therapy
- Nebulizers - modern advances
- Functional respiratory imaging: how does it help to optimize drug delivery in the lung
- Developing triple combination inhalers - the challenges
- Development of propellant free MDIs
- The ADI - low velocity aqueous spray device
- The UK regulatory future - the way forward after Brexit
- Human factor studies - hype or real need?
- Innovative filling technologies for DPIs
- MDIs getting connected - Inspair sensor converts any device into a connected device
- Smart inhalers - Improving adherence and reducing healthcare costs
- 3M Intelligent Control Inhaler
Reasons to attend
- A valuable update on the advances in inhalation technology and inhaled drug delivery
- An opportunity to keep abreast of trends in the market
- The chance to develop business relationships
Companies Participating include:
- 3M Drug Delivery
- 3P Innovation
- Aerobit Health Ltd
- Biocorp
- Boehringer Ingelheim
- Chiesi
- Esai
- Europe
- FLUIDDA
- H&S Presspart
- HCMed Innovations
- MedSpray Pharma
- Pharmaero
- Philips Healthcare
For more information about this conference visit https://www.researchandmarkets.com/research/8xbzxk/inhaled_drug
Media Contact:
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article